首页|具更佳成药性的新型三氮烯化合物的设计、合成及抗癌活性研究

具更佳成药性的新型三氮烯化合物的设计、合成及抗癌活性研究

扫码查看
以4-氨基苯甲酸为原料,经重氮化反应后与甲基烷基胺反应构建三氮烯骨架,随后将羧基与2-二乙基氨基乙氨缩合,合成了 11个l-(4-(N-(2-二乙氨基)乙基)氨甲酰基)苯基-3-甲基-3-烷基(R2)三氮烯化合物1-(4-(N-(2-二乙氨基)乙基)氨甲酰基)-3-甲基-3-环己基三氮烯(6a)~1-(4-(N-(2-二乙氨基)乙基)氨甲酰基)-3-甲基-3-(4-硝基)苄基三氮烯(6k),3步反应的总收率为46。5%~68。3%。噻唑蓝(MTT)比色法检测发现,6a、1-(4-(N-(2-二乙氨基)乙基)氨甲酰基)-3-甲基-3-苯基三氮烯(6e)~1-(4-(N-(2-二乙氨基)乙基)氨甲酰基)-3-甲基-3-(4-甲氧基)苄基三氮烯(6j)对人肝癌细胞(HepG-2)、大鼠胶质瘤细胞(C6)、人结肠癌细胞(SW620)、人前列腺癌细胞(PC-3)、小鼠黑色素瘤细胞(B16)和人非小细胞肺癌细胞(A549)共六株肿瘤细胞都有良好的抗肿瘤活性,显示出广谱的抗癌特性;其中,1-(4-(N-(2-二乙氨基)乙基)氨甲酰基)-3-甲基-3-(4-氯)苯基三氮烯(6g)的抗癌活性最为突出,对C6、SW620、PC-3和B16的IC50值均小于10 μmoUL,抗癌活性远优于阳性对照药达卡巴嗪。研究发现,当R2为具有适当吸电子效应的芳基时,化合物的抗癌活性较高。药物安全性评价发现,6e、6g、1-(4-(N-(2-二乙氨基)乙基)氨甲酰基)-3-甲基-3-(4-氯)苄基三氮烯(6h)对 C6、SW620、PC-3,6g~1-(4-(N-(2-二乙氨基)乙基)氨甲酰基)-3-甲基-3-(4-甲氧基)苯基三氮烯(6i)对B16,6e、6h、6i对HepG-2,6i对C6、SW620,其安全指数(SI)均大于2。0,其安全性高于达卡巴嗪。化合物6e、6g~6i的油水分布系数(lgP)为3。0~4。0,具有较高的膜渗透性。所有数据证实,新型三氮烯化合物6e、6g~6i具有更佳的成药性。
Design,Syntheses of Novel Triazenes with Better Druggability and the Investigation on Their Anti-tumor Activities
Eleven novel 1-(4-(N-(2-diethylamino)ethyl)aminoformoxyl)phenyl-3-methyl-3-alkyl(R2)triazenes have been designed and synthesized.Firstly,4-aminobenzoic acid,as starting material,underwent diazo reaction following the reaction with methyl alkylamine to build the triazene scaffold.Condensation of carboxylic group with 2-diethylaminoethylamine re-sulted in all the title compounds.The overall yield of these 3-step reactions was between 46.5%and 68.3%.By using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT)assay,l-(4-(N-(2-diethylamino)ethyl)aminoformoxyl)phenyl-3-methyl-3-cyclohexyltriazene(6a),l-(4-(N-(2-diethylamino)ethyl)aminoformoxyl)phenyl-3-methyl-3-phenyltriazene(6e)~1-(4-(N-(2-diethylamino)ethyl)aminoformoxyl)phenyl-3-methyl-3-(4-methoxyl)benzyltriazene(6j)were confirmed as good broad-spectrum anti-cancer agents again/st human liver cancer cells(HepG-2),rat glioma cells(C6),human colon cancer cells(SW620),human prostate cancer cells(PC-3),murine melanoma cells(B16),and human non-small-cell lung cancer cells(A549).Among them,1-(4-(N-(2-diethylamino)ethyl)aminoformoxyl)phenyl-3-methyl-3-(4-chloro)phenyltriazene(6g)show-ed as the most active agent,where IC50 values of 6g against C6,SW620,PC-3,and B16 cell lines are less than 10 pmol/L,which is far better than the positive dacarbazine.It was found that when R2 is aryl group with propriate electron-withdrawal intensity,the triazene will have good even excellent anti-cancer activity.Through drug safety evaluation,the safety indexes(SI)of 6e,6g,and l-(4-(N-(2-diethylamino)ethyl)aminoformoxyl)phenyl-3-methyl-3-(4-chloro)benzyltriazene(6h)against C6,SW620,and PC-3 cell lines,respectively;6g,6h,and 1-(4-(N-(2-diethylamino)ethyl)aminoformoxyl)phenyl-3-methyl-3-(4-methoxyl)phenyltriazene(6i)against B16 cell line respectively;6e,6h,and 6i against HepG-2 cell line respectively;6i against C6,and SW620 cell lines,respectively;were identified more than 2.0,implied better drug safety than dacarbazine.The parti-tion coefficient(lg P)of 6e,6g~6i lied between 3.0 and 4.0,meaning good membrane permeability.All the data support that the novel triazenes 6e,6g~6i have better druggability.

triazenesanti-cancerdrug safety evaluationdruggabilitydrug design-synthesis

许芹芳、胡健灵、刘园林、张超、李明月、彭姝羚、刘志军、陈河如

展开 >

暨南大学药学院中药及天然药物研究所 中药现代化与创新药物研究国际合作联合实验室 广州 510632

广州药本君安医药科技股份有限公司 广州 510663

广东省中药药效物质基础及创新药物研究重点实验室 广州 510632

暨南大学生物活性分子与成药性优化全国重点实验室 广州 510632

展开 >

三氮烯 抗肿瘤 药物安全性评价 成药性 药物设计合成

广东省自然科学基金

2021A1515011238

2024

有机化学
中国化学会,中国科学院上海有机化学研究所

有机化学

CSTPCD北大核心
影响因子:1.09
ISSN:0253-2786
年,卷(期):2024.44(5)